Glutaraldehyde: An occupational hazard in the hospital setting

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 10, 1999, Pages 1105-1109

  Di Stefano, F ^a,b   Siriruttanapruk, S ^a   McCoach, J ^a   Burge, P Sherwood ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Glutaraldehyde; Occupational asthma; Surveillance

Indexed keywords

GLUTARALDEHYDE; IMMUNOGLOBULIN E ANTIBODY;

AIR MONITORING; ANTIBODY TITER; ARTICLE; ATOPY; CLINICAL ARTICLE; FORCED EXPIRATORY VOLUME; HEALTH SURVEY; HOSPITAL PERSONNEL; HUMAN; OCCUPATIONAL ASTHMA; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROVOCATION TEST; SMOKING; WORKROOM AIR;

ADULT; AIR POLLUTANTS, OCCUPATIONAL; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODY SPECIFICITY; BRONCHIAL PROVOCATION TESTS; FALSE POSITIVE REACTIONS; FEMALE; GLUTARAL; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PEAK EXPIRATORY FLOW RATE; PERSONNEL, HOSPITAL; RADIOALLERGOSORBENT TEST;

EID: 0032844860     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00239.x     Document Type: Article

References (13)

1. Gannon PFG, Bright P, Campbell M, O'Hickey SP, Burge PS. Occupational asthma due to glutaraldehyde and formaldehyde in endoscopy and x-ray departments. Thorax 1995;50:156-159.
2. Curran AD, Burge PS, Wiley K. Clinical and immunologic evaluation of workers exposed to glutaraldehyde. Allergy 1996;51:826-832.
3. Norback D. Skin and respiratory symptoms from exposure to alkaline glutaraldehyde in medical services. Scand J Work Environ Health 1988;124:366-371.
4. Leinster P, Baum JM, Baxter PJ. An assessment of exposure to glutaraldehyde in hospitals: typical exposure levels and recommended control measures. Br J Ind Med 1993;50:107-111.
5. Gannon PFG, Burge PS. The SHIELD scheme in the West Midlands Region, United Kingdom. Br J Ind Med 1993;50:791-796.
6. Gannon PFG, Newton DT, Belcher J, Pantin CFA, Burge PS. Development of OASYS-2: a system for the analysis of serial measurement of peak expiratory flow in workers with suspected occupational asthma. Thorax 1996;51:484-489.
7. Vandenplas O, Delwiche JP, Jaman J, Vande Weyer R. Increase in nonspecific bronchial hyperresponsiveness as an early marker of bronchial response to occupational agents during inhalation challenges. Thorax 1996;51:472-478.
8. Bright P, Burge PS. The diagnosis of occupational asthma from serial measurements of lung function at and away from work. Thorax 1996;51:857-863.
9. Gannon PFG, Burge PS. Serial peak expiratory flow measurements in the diagnosis of occupational asthma. Eur Respir J 1997;10 Suppl 24:57s-63s.
10. Burge PS, O'Brien PM, Harries MG. Peak flow rate in the diagnosis of occupational asthma due to isocyanates. Thorax 1979;34:317-322.
11. Burge PS. Single and serial measurements of lung function in the diagnosis of occupational asthma. Eur J Respir Dis 1982;63 Suppl 123:47-59.
12. Malo JL, Cotè J, Cartier A, et al. How many times per day should peak expiratory flow rates be assessed when investigating occupational asthma? Thorax 1993;48:1211-1217.
13. Venables KM, Topping MD, Nunn AJ, Howe W, Newman Taylor AJ. Immunologic and functional consequences of chemical (tetraphthalic anhydride) induced asthma after four years of avoidance of exposure. J Allergy Clin Immunol 1987;80:212-218.